COVID-19 Updates: Dr. Hala Saad

Over the past sev­er­al weeks, we’ve seen restric­tions sur­round­ing COVID-19 loos­ened, but remain­ing aware of the lat­est with the virus is impor­tant. We spoke with QMG Infec­tious Dis­ease Physi­cian Dr. Hala Saad about some of the lat­est devel­op­ments with COVID-19.

Has COVID become an endem­ic ver­sus a pan­dem­ic? What’s the dif­fer­ence?
In epi­demi­ol­o­gy, endem­ic’ means that the dis­ease is always present at a base­line lev­el, so it’s not down to zero. There are observ­able cas­es. But unlike a pan­dem­ic or epi­dem­ic, in which a disease’s behav­ior is often sur­pris­ing or unex­pect­ed, an ill­ness that has become endem­ic has become more pre­dictable. I do not think we are at an endem­ic lev­el yet. We are still see­ing unpre­dictable surges of the dis­ease vari­ants globally.”

How high is the risk of Omicron’s BA.2 vari­ant? We will see anoth­er spike in cas­es in the U.S.?
BA.2 vari­ant is now the dom­i­nant vari­ant glob­al­ly, and it is more trans­mis­si­ble so we will def­i­nite­ly start see­ing more of it here, but it is not like­ly to cause severe disease.”

Should we be mask­ing up and tak­ing more pre­cau­tions with the news of BA.2?
We should con­tin­ue to fol­low the CDC guide­lines in terms of mask­ing and precautions.”

What makes BA.2 dif­fer­ent from oth­er vari­ants?
It is more con­ta­gious, also it is called the stealth’ virus because it is more dif­fi­cult to diag­nose, but it is less like­ly to cause disease.”

Is being vac­ci­nat­ed and boost­ed still the best pro­tec­tion against this virus?
As with the oth­er vari­ants in the Omi­cron fam­i­ly, vac­cines are less effec­tive against BA.2 than against pre­vi­ous vari­ants and pro­tec­tion declines over time. How­ev­er pro­tec­tion is restored by a vac­cine boost­er par­tic­u­lar­ly for pre­vent­ing hos­pi­tal­iza­tion and death.”

The Food & Drug Admin­is­tra­tion (FDA) recent­ly approved a fourth boost­er for adults 50 and over. Can you explain the FDA’s announce­ment?
Emerg­ing evi­dence sug­gests that a sec­ond boost­er dose of an mRNA COVID-19 vac­cine improves pro­tec­tion against severe COVID-19 and is not asso­ci­at­ed with new safe­ty concerns.”

For more infor­ma­tion on the COVID vac­cine, vis­it qmg​vac​cines​.com.

Health Topics: